<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2014-9-84-89</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-637</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВЕДЕНИЕ БЕРЕМЕННОСТИ И РОДОВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MANAGEMENT OF PREGNANCY AND CHILDBIRTH</subject></subj-group></article-categories><title-group><article-title>Патогенез и профилактика тромбоэмболических осложнений, связанных с использованием вспомогательных репродуктивных технологий</article-title><trans-title-group xml:lang="en"><trans-title>Pathogenesis and prevention of thromboembolic complications associated with the use of assisted reproductive technologies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акиньшина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Akinshina</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макацария</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Makatsaria</surname><given-names>A. D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бицадзе</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Bitsadze</surname><given-names>V. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный университет им. И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>the Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2014</year></pub-date><volume>0</volume><issue>9</issue><fpage>84</fpage><lpage>89</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Акиньшина С.В., Макацария А.Д., Бицадзе В.О., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Акиньшина С.В., Макацария А.Д., Бицадзе В.О.</copyright-holder><copyright-holder xml:lang="en">Akinshina S.V., Makatsaria A.D., Bitsadze V.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/637">https://www.med-sovet.pro/jour/article/view/637</self-uri><abstract><p>Тромботические осложнения являются наиболее серьезными, потенциально смертельными осложнениями вспомогательных репродуктивных технологий, которые в большинстве случаев связаны с синдромом гиперстимуляции яичников. В статье описаны современные аспекты патогенеза синдрома гиперстимуляции яичников, патогенез тромбоэмболических осложнений и значение генетических и приобретенных тромбофилий для их развития, методики оценки факторов риска тромботических осложнений перед использованием вспомогательных репродуктивных технологий и рекомендации по профилактике тромбоэмболических осложнений у женщин, включенных в программы ЭКО.</p></abstract><trans-abstract xml:lang="en"><p>Thrombotic complications are the most serious complications of assisted reproductive technologies which can be fatal, in most cases associated with ovarian hyperstimulation syndrome. The article describes the modern aspects of the pathogenesis of ovarian hyperstimulation syndrome, of thromboembolic complications and the role of genetic and acquired thrombophilia in their development, methods to assess risk factors for thrombotic complications before applying assisted reproductive technologies and recommendations for the prevention of thromboembolic complications in women undergoing IVF treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>репродуктивные технологии</kwd><kwd>тромбоэм-болические осложнения</kwd><kwd>профилактика</kwd><kwd>низкомолекулярный гепарин</kwd><kwd>бемипарин</kwd><kwd>reproductive technologies</kwd><kwd>thromboembolic complications</kwd><kwd>prevention</kwd><kwd>low-molecular-weight heparin</kwd><kwd>bemiparin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
